Two HHV8-related illnesses in a HIV-negative patient: Kaposi's sarcoma and multicentric Castleman's disease. Response to treatment with rituximab and CHOP;Dos enfermedades relacionadas con el VHH-8 en un paciente VIH-negativo: Sarcoma de Kaposi y enfermedad de Castleman multicéntrica. Respuesta a tratamiento con rituximab y CHOP

Actas Dermo-Sifiliograficas

Volumn 97, Issue 6, 2006, Pages 385-390

  Pastor Nieto, M A ^a,e   Vasco, B ^b   Mosquera, J M ^c   Deben G ^c   Bautista, P ^a   Requena, L ^d  

^a HOSPITAL SANTA BÁRBARA   (Spain)

^b Hospital Virxe da Xunqueira   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^e NONE   (Spain)

Author keywords

Human herpes virus 8; Kaposi's sarcoma; Multicentric Castleman's disease; Rituximab

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD EXAMINATION; CASE REPORT; CLINICAL EXAMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; KAPOSI SARCOMA; MALE; POLYMERASE CHAIN REACTION; REMISSION; TREATMENT RESPONSE; TUMOR BIOPSY;

EID: 33845358605     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73425-1     Document Type: Article

References (15)

1. Geraminejad P, Memar O, Aronson I, Rady PL, Hengge U, Tyring S. Kaposi's sarcoma and other manifestations of human herpesvirus 8. J Am Acad Dermatol. 2002;47: 641-55.
2. Ioachim HL, Ratech H. Ioachim's lymph node pathology. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 2002.
3. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem C, Babinet P, et al. Kaposi's sarcoma associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood. 1995;86:1276-80.
4. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vI16, in HIV-seronegative Castleman's disease. Am J Pathol. 1997;151:1517-22.
5. Larroche C, Cacoub P, Soulier J, Oksenhendler E, Clauvel JP, Piette JC, et al. Castleman disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol. 2002;69:119-26.
6. Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I; Viard JP, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003;102:2786-8.
7. Corbellino M, Bestetti G, Scalamogna C, Calattini S, Galazzi M, Meroni L, et al. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Gastleman disease with anti-CD 20 monoclonal antibody therapy. Blood. 2001;98:3473-5.
8. Casquero A, Barroso A, Fernández-Guerrero, Górgolas M. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol. 2006;85:185-7.
9. Clifford KS, Demierre MF. Progression of classic Kaposi's sarcoma with rituximab. J Am Acad Dermatol. 2005;53:155-7.
10. Dickson D, Ben-Ezra JM, Reed J, Flax H, Janis R. Multicentric giant lymph node hyperplasia, Kaposi's sarcoma and lymphoma. Arch Pathol Lab Med. 1985;109:1013-8.
11. Mandel C, Silberstein M, O Hennessy O. Case report: fatal pulmonary Kaposi's sarcoma and Castleman's disease in a renal transplant recipient. Br J Rad. 1993;66:264-5.
12. Nampoory MR, Johny KV, Sarkar C, Al-Masry I, Al-Hilali N, Anim JT. The dialysed patient with both Castleman disease and Kaposi's sarcoma. Nephrol Dial Transplant. 1998;13:2373-6.
13. Codish S, Abu-Shakra M, Ariad S, Zirkin HJ, Yermiyahu T, Dupin N, et al. Manifestations of three HHV-8-related diseases in an HIV-negative patient: immunoblastic variant multicentric Castleman disease, primary effusion lymphoma and Kaposi's sarcoma. Am J Hematol. 2000;65:310-4.
14. Bollen JM, Polstra AM, van der Kuyl AC, Weel JF, Noorduyn LA, van Oers MHJ, et al. Multicentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case report. BMC Blood disorders. 2003;3:3.
15. Boulanger E, Hermine O, Fermand JP, Radford-Weiss I, Brousse N, Meignin V, et al. Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients. Am J Hematol. 2004;76:88-91.